Corporate & Industry Trends
Eli Lilly Targets Telehealth Firms Over Unauthorized Weight-Loss Drug Variants
Pharma giant intensifies legal action against Mochi Health, Fella Health, Willow Health, and Henry Meds for distributing unapproved tirzepatide formulations